Especialista en Medicina Materno-Fetal. Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med ; Fetal middle cerebral artery Doppler velocimetry in cases of rhesus alloimmunization. J Matern Fetal Neonatal Med ;
|Published (Last):||20 August 2007|
|PDF File Size:||4.17 Mb|
|ePub File Size:||3.11 Mb|
|Price:||Free* [*Free Regsitration Required]|
These images are a random sampling from a Bing search on the term "Hemolytic Disease of the Newborn. Search Bing for all related images. Started in , this collection now contains interlinked topic pages divided into a tree of 31 specialty books and chapters. Content is updated monthly with systematic literature reviews and conferences. Although access to this website is not restricted, the information found here is intended for use by medical providers.
Patients should address specific medical concerns with their physicians. Toggle navigation. Hematology and Oncology Chapter. Page Contents Images: Related links to external sites from Bing. Related Studies. Trip Database TrendMD. Ontology: Erythroblastosis, Fetal C Definition NCI A disorder of the fetus or newborn that occurs when fetal cells that are coated with IgG alloantibodies from the mother attack antigens inherited from the father.
Severity can range from absence of symptoms to death. Definition CSP hemolytic anemia of the fetus or newborn caused by transplacental transmission of maternally formed antibody, usually secondary to an incompatibility between the blood groups of mother and offspring. Related Topics in Hematology and Oncology. Neonatology Chapters.
Neonatology - Hematology and Oncology Pages. Hemolytic Disease of the Newborn Hydrops fetalis. Back Links pages that link to this page. Search other sites for 'Hemolytic Disease of the Newborn'. A disorder of the fetus or newborn that occurs when fetal cells that are coated with IgG alloantibodies from the mother attack antigens inherited from the father.
Disease or Syndrome T P55 , P Malattia emolitica del feto o del neonato dovuta ad altra non specificata isoimmunizzazione , Malattia emolitica da altra e non specificata isoimmunizzazione fetale o neonatale , Malattia emolitica del feto o del neonato dovuta a isoimmunizzazione , Malattia emolitica fetale o neonatale da isoimmunizzazione , Malattia emolitica del neonato , Eritroblastosi fetale.
Vastasyntyneen hemolyyttinen tauti.
Aloinmunización RH: manejo anteparto. Revisión de la literatura
When any fetal blood group factor inherited from the father is not possessed by the mother, antepartum or intrapartum fetal-maternal bleeding may stimulate an immune reaction in the mother Maternal immune reactions also can occur from blood product transfusion. The formation of maternal antibodies, or"alloimmunization,' may lead to various degrees of transplacental passage of these antibodies into the fetal circulation. Depending on the degree of antigenicity and the amount and type of antibodies involved, this transplacental passage may lead to hemolytic disease in the fetus and neonate. Undiagnosed and untreated, alloimmunization can lead to significant perinatal morbidity and mortality. Advances in Doppler ultrasonography have led to the development of noninvasive methods of management of alloimmunization in pregnant women. Together with more established protocols, Doppler ultrasound evaluation may allow for a more thorough and less invasive workup with fewer risks to the mother and fetus.
ACOG Practice Bulletin No. 75: Management of Alloimmunization During Pregnancy
ISSN X. We present an experience in the management of patients highly sensitized by Rh isoimmunization, analyzing the usefulness of evaluating of fetal blood velocity by Color-Doppler, through the measurment of the maximal systolic velocity MSV of the middle cerebral artery MCA. In three cases presenting this illness, 19 intravascular transfusions were carried out. In 14 of these transfusions, moderate or severe anemia was found, which was correctly diagnosed by means of the measurement already pointed out. We emphasize the benefits of a non-invasive method in the management of fetal anemia caused by isoimunization or associated to other morbid conditions, and we feel that a new field is open to future research.